Cancer Center, Sun Yat-sen University
Guangzhou, Guangdong, 510060, China
NCT Number: NCT03240835
The purpose of this study is to study the function of pre-albumin, retinol conjugated protein and transferrin in early malnutrition detecting and nutritional status dynamic monitoring for local advanced nasopharyngeal carcinoma patients with chemoradiotherapy.
Looking for future studies?
Notify Me18 year–60 year
All sexes
Observational
Guangzhou, Guangdong, 510060, China
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
NACt:cisplatin 75 mg/m2 intravenous infusion in day1,docetaxel 75 mg/m2 intravenous infusion in day1,both drugs are given every 3 weeks, two cycles.
CCRT: cisplatin (100mg/m2 on day 1) every three weeks for two cycles.
intensity modulation radiation therapy
Time frame: baseline and during treatment
to evaluate the changes of PA/RBP/TRSF during the treatment
Time frame: baseline and during treatment
to compare the change of weight loss during treatment
Time frame: baseline and during treatment
To observe the complete blood cell count and blood biochemical examination during treatment
Time frame: baseline and during treatment
To evaluate the acute toxicity with Common Terminology Criteria For Adverse Events (CTCAE) 4.0
Zhao Chong
Other
The Function of Pre-Albumin, Retinol Conjugated Protein and Transferrin in Early Malnutrition Detecting and Nutritional Status Dynamic Monitoring for Local Advanced Nasopharyngeal Carcinoma Patients With Chemoradiotherapy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02575547
Carcinoma, Head and Neck Neoplasms
Guangzhou, Guangdong, China
View Trial DetailsNCT04528394
Carcinoma, Head and Neck Neoplasms
Shanghai, Shanghai Municipality, China
View Trial DetailsNCT03848286
Carcinoma, Disease Attributes
Beijing, Beijing Municipality, China
View Trial DetailsNCT02633202
Carcinoma, Head and Neck Neoplasms
Guangzhou, Guangdong, China
View Trial Details